Portugal Medical Devices Market Analysis Sample Report

Portugal Medical
Devices Market
Analysis
www.insights10.com
A sample report on
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Portugal Medical
Devices Market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, types of clinical diagnostics, point-of-care testing,
main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Portugal
Medical Devices Market, and offers unmatched value, accuracy, and
expert insights

3
A Sample Report on Portugal Medical Devices Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Medical Devices Overview 12-25
1.1. Overview
1.2. Portugal Overview
1.3. Economic Overview: Portugal
1.4. Medical Devices Market in Portugal
1.5. Medical Devices Market in Portugal
1.6. Healthcare Scenario in Portugal
1.7. Health Insurance Coverage: Portugal
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 26-30
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. Product Type
2.2.2. End User
3. Market Dynamics 31-35
3.1. Market Growth Drivers
3.1.1. Portugal Medical Devices Market Driver 1
3.2. Market Restraints
3.2.1. Portugal Medical Devices Market Restraint 1

6
Table of Content
CONTENT PG. NO.
4. Competitive Landscape 36-46
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. SunMed
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Werfen
4.2.2.1. Overview

7
Table of Content
CONTENT PG. NO.
4.2.3. B. Braun Medical
4.2.3.1. Overview
4.2.4. Surgicaleuro
4.2.4.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.5. Abbott
4.2.5.1. Overview
4.2.6. Alcon
4.2.6.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.7. Cardinal Health
4.2.7.1. Overview
4.2.8. Medtronic
4.2.8.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.9. Merit Medical
4.2.9.1. Overview
4.2.10. Stryker
4.2.10.1. Overview

11
Table of Content
CONTENT PG. NO.
5. Reimbursement Scenario 47-52
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
6. Methodology & Scope 53-58

Portugal Medical Devices Market Analysis
1. Medical Devices Overview

13
1.1 Statistics at a Glance: The Scenario of Medical Devices in the World
Scope of Medical Devices ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2 Mn
different kinds of
medical devices are
available in the
global market
7000
of the medical devices fall
into generic devices group
$562 Bn
is the revenue forecast for medical devices industry by 2024
40%
US is the largest
medical device
market with 40% of
global MedTech
market
70%
is the revenue share of the
largest medical device
equipment manufacturers
located in the US

14
1.1 Statistics at a Glance: The Scenario of Medical Devices in the World
(continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$XX Bn by 2027
Asia
-Fastest CAGR
Africa
~Market Size of
$XX Bn
Portugal Market
~$XX Mn Market
Illustrative

15
1.2 Portugal Overview
1.03 Mn
Is the population of
Portugal, in 2022
46.2
Is the median age
in Portugal, in 2022
254 Bn
Is the Gross
Domestic Product
(GDP) in Portugal in
2021
$2,457
per capita was the
amount of national
health expenditures in
2021
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

16
1.3 Economic Overview: Portugal
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Portugal, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Portugal, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Statistics at a Glance: The Scenario of Medical Devices in Portugal
Scope of Medical Devices
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Portugal
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
200
companies
distributing medical
devices in Portugal
105
there are a total of 105 MRI
units in Portugal
20%
of the medical device expenditures in Portugal are made
by the private sector
4.05
is the density of
radiotherapy
devices per
1,000,000
population
80%
of the medical device
expenditures in Portugal are
made by the public sector

18
1.5 Pharmaceutical in Portugal
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Portugal Pharmaceutical Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Medical Devices market in Portugal, which includes the market size, current trends
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
1.6 Healthcare Scenario in Portugal
Medical Devices Drug Development Process: The process of developing a Medical Devices drug is complex and involves many stages, from
preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the Medical Devices drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating Medical Devices
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative

20
1.6 Healthcare Scenario: Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative

21
1.7 Health Insurance Coverage: Portugal
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

22
1.8 Budget of Portugal Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

23
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

24
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Oracle acquisition of
Cerner
Acquisition $28.3 Bn June, 2022
▪ Oracle’s acquisition of Cerner is big tech’s latest foray into the
healthcare system, promising better outcomes
▪ Oracle acquire Cerner through an all-cash tender offer for $95.00
per share, or approximately $28.3 Bn in equity value
▪ Cerner is a leading provider of digital information systems used
within hospitals and health systems to enable medical
professionals to deliver better healthcare to individual patients
and communities
GSK acquisition of
BELLUS Health
Acquisition $2 Bn April 2023
▪ GSK has acquire BELLUS for US$14.75 per share of common
stock in cash representing an approximate total equity value of
US$2.0 billion
▪ BELLUS is a late-stage biopharmaceutical company working to
better the lives of patients suffering from persistent cough
▪ Acquisition further strengthens specialty medicines and
respiratory pipeline with camlipixant, a highly selective P2X3
antagonist and potential best-in-class treatment for refractory
chronic cough
Latest Deals In Portugal
Illustrative

25
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In Portugal

2. Market Size and Forecasting

27
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Portugal Medical Devices Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Portugal Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Portugal Market Size (Bn
$)
61 74 84 87 91 95 99 106
Illustrative

28
2.2 Snapshot of Medical Devices Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Portugal Medical Devices Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
• Orthopedic Devices
• Cardiovascular Devices
• Diagnostic Imaging
• IVD
• MIS
• Wound Management
Product Type
• Hospitals and ASCs
• Clinics
• Others
End User
• Diabetes Care
• Ophthalmic
• Dental
• Nephrology
• General Surgery
• Others

29
Portugal Medical Devices Market Share, By Product Type (2022)
▪ Orthopedic devices market in Portugal
is a significant component of the overall
medical devices treatment market
▪ It has the maximum market share in
Portugal medical devices market with
approximately xx%
final report
2.2.1 Market Segmentation: By Product Type
Orthopedic
Devices
Cardiovascular
Devices
Diagnostic
Imaging
IVD
MIS
Wound
Management
Diabetes Care
Ophthalmic
Dental
Nephrology
General SurgeryOthers

30
Portugal Medical Devices Market Share, By End User (2022)
Hospitals and
ASCs
Clinics
Others
2.2.2 Market Segmentation: By End User
▪ Hospitals and ASCs market in Portugal
is a significant component of the overall
medical devices market
▪ It has the maximum market share in
Portugal Medical Devices market with
approximately xx%
final report

3. Market Dynamics

32
3.1 Market growth drivers
▪ When there are public health or demonstrated economic advantages, the
State can pay the procurement of medical devices to NHS and other
public health subsystem recipients, upon request of the maker or his
authorized agent
▪ This is driving the demand for medical devices and creating opportunities
for growth in the medical devices market
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 Reimbursement of medical devices is addressed in Chapter III of Portuguese Decree-Law n.o 97/2015, as
revised by Decree-Law n.o 115/20172
Incidence of Medical Devices in Portugal
Illustrative

33
3.1 Market growth drivers (continued)
Top countries that are leveraging
technology in their fight against Medical
Devices
United States
Japan
Germany
South Korea
China
United Kingdom
France
Canada
Australia
Israel
Switzerland
Singapore
Sweden
Netherlands
Italy
Spain
Belgium
Denmark
Austria
Norway
3.1.2 Portugal National Health Service got the most substantial financing from the State Budget in 2022, totaling $12
Bn, an increase of more than $756 Mn over the previous State Budget
▪ Portuguese medical sector offers prospects for novel
medical devices and diagnostic equipment
▪ Advanced digital solutions that interact with healthcare and
telemedicine equipment, tele triage, teleconsultation, and
telemonitoring systems have potential
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
Illustrative

34
3.1 Market growth drivers (continued)
Fundings from government and other
organizations
3.1.3 In Portugal in 2021, the retired population has a greater proportion of persons with chronic diseases or long-
standing health issues with a ratio of 71.1%
▪ Chronic diseases such as cardiovascular disease, diabetes,
respiratory problems, and cancer are becoming more
common in Portugal
▪ Medical devices play a crucial role in the diagnosis,
treatment, and management of these conditions
▪ Rising prevalence of chronic illnesses boosts demand for
medical equipment, fuelling market expansion
Source Year Fund ($)
National Medical
Devices Institute
(NCI)
2021 $ 6.4 Bn
Centers for Disease
Control and
Prevention (CDC)
2021 $ 501 Mn
American Medical
Devices Society
(ACS)
2020 $ 150 Mn
Susan G. Komen 2020 $ 98 Mn
Illustrative

35
3.2 Market restraints
3.2.1 Portugal's
pharmaceutical product
exports accounted for
up to $125 Mn, while
imports accounted for
up to $353 Mn, resulting
in a $227 Mn negative
trade deficit
▪ Low health expenditure,
particularly in the public sector, is
limiting the expansion of the
Portugal medical device market
▪ Budget restrictions can have an
influence on market growth by
reducing medical device
adoption and penetration
3.2.2 Regulatory compliance
and securing market licenses
for medical devices may be a
time-consuming and difficult
procedure in Portugal
▪ Adhering to the requirements
established by the Portuguese
National Authority of Medicines
and Health Products
(INFARMED) and the European
Union's Medical Device
Regulation (MDR) can be difficult
for manufacturers, particularly
small and medium-sized firms
(SMEs)
3.2.3 To control expenses, health
insurance companies,
government healthcare programs,
and hospitals frequently negotiate
cheaper rates for medical devices
▪ Pricing pressure can have an
impact on the profitability of
medical device makers and
discourage investment in R&D
▪ Furthermore, reimbursement
regulations may insufficiently
cover the price of some medical
devices, making it difficult for
healthcare providers to sell them
to patients and, as a result,
restricting the market growth
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

37
4.1 Major Market Share
XX
Other
▪ Portugal Medical Devices market is a
highly competitive space, with many
companies developing and marketing
Medical Devices treatments
▪ Some of the top companies in Portugal
Medical Devices market based on revenue
and market share include
▪ SunMed is a Swiss multinational
healthcare company that develops and
markets Medical Devices treatments,
including targeted therapies and
immunotherapies
▪ In 2020, SunMed's oncology sales were
approximately $24 Bn, making it one of the
largest players in Portugal Medical Devices
market
Revenue of Major players in Portugal Medical Devices
Market ($ Mn)
Illustrative

38
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 SunMed
3 B. Braun Medical
5 Abbott
7 Cardinal Health
9 Merit Medical
2 Werfen
4 Surgicaleuro
6 Alcon
8 Medtronic
Stryker
10
Key Note:

39
4.2.1 SunMed
Founded in: 1981
HQ: Michigan, US
Type: Private
Revenue: $37.9 Mn
Website: www.sunmed.com
▪ SunMed is a market leader in medical device production, with one
of the most diverse portfolios of anesthetic and respiratory care
devices
▪ SunMed is a global pioneer in consumable goods used to assure
quality breaths
▪ Salter Labs, Westmed, Ventlab, and Ethox are all part of the
SunMed brand family, which serves 97 countries worldwide
Solutions offered by SunMed
➢ Acute Care
➢ Home Care
➢ EMS
➢ Surgery Centers
➢ OEM and Private Label
Air-Q®3 Supraglottic
Airway
The Pulset™ ABG Syringe
CapnoVue® CO2 Masks Air-Q3 Intubating Laryngeal Airway
SafeT™ T-Piece Infant
Resuscitator with Pop-
Off
SunStim™ Pro
NebuTech® Nebulizer
with B/V Filter
Infu-Surg® Pressure Infusion Bag
Products Recent Activity / Press Coverage
SunMed has completed its acquisition of Vyaire Medical's Respiratory and
Anesthesia Consumables business
SunMed Partnership Aids In Successful Group Purchasing Agreement
SunMed has achieved European Union (EU) Medical Device Regulation
(MDR) approval for nine categories of its medical devices

40
4.2.1 SunMed (continued)
SunMed Brands
Manufacturer and distributor of respiratory and critical care equipment. Ventilators and hyperinflation systems are available from
the firm for use in anesthesia, respiratory care, critical care, and emergency medical services
Salter Labs is a global leader in the production of disposable respiratory devices for hospitals and home care
Disposable medical device designer and producer. The company's safe and innovative healthcare goods are custom-made to
meet the demands and specifications of its customers
Westmed, Inc. is a global manufacturer of anesthetic, respiratory treatment, and critical care products for hospitals, alternative
care facilities, and foreign healthcare markets

41
Company Name Type
Amount /
Duration
Year Key Pointers
Vyaire Medical
Acquisition - May, 2023
▪ SunMed has completed the acquisition of Vyaire Medical's
respiratory and anesthesia consumables business
▪ SunMed will become a leading manufacturer wholly dedicated to
airway management and operative care, with a more
comprehensive offering for practitioners, serving as a one-stop
source for the highest-quality consumable respiratory and
anesthesia medical products that support the best patient
outcomes
Securisyn Medical
Partnership - July,2022
▪ SunMed and Securisyn Medical Form Strategic Partnership In
Manufacturing And Distribution
▪ SunMed's considerable engineering, development,
manufacturing, quality, regulatory, and commercialization
experience in medical devices will be combined with Securisyn's
award-winning family of clinically differentiated breathing tube
securement devices using patented InterlockTM technology to
accelerate time to market at scale
Latest Deals - Mergers and Acquisitions

42
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
▪ According to SunMed's 2020 financial
report, the company had sales of CHF 58.3
Bn (Swiss Francs) in 2020
▪ This is equivalent to approximately $63.3
Bn USD, based on exchange rates at the
end of 2020
▪ Company's Pharmaceuticals Division
generated sales of CHF 49.9 Bn in 2020,
while the Diagnostics Division generated
sales of CHF 8.4 Bn
▪ Revenue generated by SunMed in 2020
reflects the company's continued growth
and success in the healthcare industry
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

43
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for
Medical Devices
Recent Activity / Press Coverage
Illustrative

44
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

45
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

46
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
▪ Please be aware that this sample report is
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

48
5.1 Reimbursement Regulation
▪ Portugal, being a European Union (EU) member, adheres to European
Commission (EC) directives and uses the same medical device
categorization as the rest of the EU. Medical equipment is categorized into
four risk classes: I, IIa, IIb, and III
▪ Before manufacturers may begin selling their medical devices in Portugal,
they must ensure that their product has been CE-marked, which indicates
compliance with current EU standards and allows the equipment to be
marketed freely in the EU market
▪ Conformity testing is required for all medical equipment. However, for some
classes, a third party - the Notified Body - must be involved in this
evaluation. The Notified Body is a national authority-appointed evaluation
body that is recognized by the EC, which grants it a four-digit identifying
identifier
▪ In addition to CE marking, all classes of medical devices that are to be
placed on the Portuguese market must go through a device registration
process, even though the requirements for Class I medical device
registration differ from those for Class IIa, IIb, III, and implantable active
medical devices
Medicare and Medicaid together provide
health insurance coverage for more than
4 in 10 Americans
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative

49
5.1 Reimbursement Regulation (continued)
▪ INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde / National Authority of Medicines and Health
Products):
o Portuguese Regulatory Authority (RA) is an institution under the Portuguese Ministry of Health that assesses, authorizes,
regulates, and oversees the market, regardless of device origin, to ensure public health protection
▪ Medical Device Regulation (MDR):
o EU's Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) create standardized
requirements for medical device safety, performance, and quality
o Manufacturers must follow these laws in order to receive CE marking, which demonstrates compliance with EU standards
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

50
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
 Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
 Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

51
5.2 Reimbursement Process for Diagnosis of a Disease
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

52
5.3 Reimbursement Process for Treatment of a Disease
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Medical Devices and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Medical Devices
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Portugal Medical Devices Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Portugal Medical Devices Market Analysis Sample Report

Similar to Portugal Medical Devices Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Portugal Medical Devices Market Analysis Sample Report